Advertisement
Screener

RECURSION PHARMACEUTICALS, INC. (RXRX) ROE

RECURSION PHARMACEUTICALS, INC. (RXRX) ROE

  • 2026-06-30: ROE -56.71%.
  • 2026-03-31: ROE -54.62%.
  • 2025-12-31: ROE -57.01%.
  • 2025-09-30: ROE -68.35%.

Complete source-backed roe history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-56.71%
2026-03-31-54.62%
2025-12-31-57.01%
2025-09-30-68.35%
2025-06-30-70.62%
2025-03-31-61.54%
2024-12-31-44.81%
2024-09-30-72.01%
2024-06-30-64.15%
2024-03-31-88.27%
2023-12-31-70.79%
2023-09-30-66.80%
2023-06-30-55.44%
2023-03-31-57.84%
2022-12-31-49.29%
2022-09-30-63.63%
2022-06-30-53.45%
2022-03-31-42.90%
2021-12-31-34.35%
2021-09-30-24.59%
2021-06-30-19.26%
2021-03-3142.61%
2020-12-3142.18%

Annual ROE

DateROE
2025-12-31-57.01%
2024-12-31-44.81%
2023-12-31-70.79%
2022-12-31-49.29%
2021-12-31-34.35%
2020-12-3142.18%
2019-12-3149.80%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Vericel Corp (VCEL)United States$2.011B93.97
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Greenland Mines Ltd (GRML)United States$2.362B
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51